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Dear Editor,
I read the article by Auluck A with great interest(1). A new 
patient with Dyskeratosis congenita (DC) who developed 
oral leukoplakic lesions has been described in this article. 
The author first has pointed out that most of the cases 
of DC have been described by dermatologists or pediatri-
cians, and then emphasized the critical importance of bet-
ter awareness about DC among dentists because of the oral 
leukoplakic lesions which take part in the classical triad of 
DC and have malignant transformation potential.
In the case presentation section of the article, the phases 
of the patient went through starting from childhood till 
the time of the diagnosis were described in detail. The 
obtained data proved to be typical for the clinical progress 
of DC, and will be quite useful for the target clinicians 
(i.e., dentists) in recognizing the disease. 
In the discussion section of the article, it has been empha-
sized that Fanconi anemia (FA) is the major clinical con-
dition that shoud be differentiated from DC. I do agree 
with the author that FA is a significant disease in the 
differential diagnosis of DC. Indeed, DC and FA resemble 
each other in terms of many physical features (low birth 
weight, growth retardation, cutaneous manifestations, 
head and skeletal abnormalities, hypogonadism, deafness), 
laboratory findings (cytopenias, increased HbF), and 
clinical characteristics (susceptibility to cancer in young 
ages), and thus they might be easily confused by the cli-
nicians who are not professional in hematology. Right at 
the point where the differential diagnosis is being made 
between the two diseases, the author is stating that their 
modes of inheritance are different and that, unfortunately, 
FA is inherited autosomal dominantly. This particular 
distinction is the one and only reason I am writing this 
letter. Traditionally known that FA is an autosomal 
recessive (AR) disorder(2,3). In fact it is the prototype 
of the autosomal recessively inherited disorders and has 
already been introduced to the medical literature as an AR 
disorder since its description. At this time, it is known, 
thought and lived to be an autosomal recessive disease. 
Fanconi anemia is one of the diseases that some ethnic 
populations, are being tested for carrier status(4,5). It is 
worth remembering that, premarital carrier screening tests 
are carried out for recessively inherited diseases. Because 
in autosomal recessive disorders, like FA, both parents 
carry one mutated allele and are referred to as ‘carriers’. 
Each pregnancy has a 25% risk of passing on 2 mutated 
alleles resulting in an affected child. Interestingly, despite 
the AR inheritance FA has a slight male predominance 
(male:female 1.3). This discrepancy has been explained 
only recently: in 2004 Meetei et al have described a 
genetic subtype of FA with X-linked inheritance(6). In 
summary, to date, twelve genetic subtypes, also known as 
complementation groups, have been distinguished in FA: 
FA-A, B, C, D1, D2, E, F, G, I, J, L, and M. The mode of 
inheritance for all groups is autosomal recessive, except 
for FA-B, which is X-linked(7).   
Obviously, for the dentists -the target clinicians of the 
article- the fundamental point is to be able to diagnose the 
DC patients and to get the precancerous oral leukoplakic 
lesions under control in the early stage as much as possible. 
Nonetheless, my position is this: It is crucial for the clini-
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cians who surely will be a part of the team managing the 
DC patients to be armed with the right knowledge that the 
differential diagnosis between DC and the other disease, 
which is going to be primarily FA, has to do with the mode 
of inheritance. Specifically, the right knowledge is that of 
the twelve genetic subtypes of  FA, 11 are AR and 1 of 
them is X-linked as far as inheritance is concerned.
I would like to thank to Dr Auluck both for the new case 
of DC described in the article, and via the present case, 
for the opportunity of reminding the current mode of 
inheritance of Fanconi anemia. 
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